Skip to main content

Table 1 Clinical characteristics of the participants

From: Effusion detected by ultrasonography and overweight may predict the risk of knee osteoarthritis in females with early knee osteoarthritis: a retrospective analysis of Iwaki cohort data

 

Male

 

Female

 

Normal (n=165)

EKOA (n=17)

p value

Normal (n=184)

EKOA (n=38)

p value

Age, years

50.6±13.9

55.7±14.1

0.118

49.8±13.1

53.7±10.8

0.039

BMI, kg/m 2

23.5±2.8

24.6±2.3

0.092

21.7±2.8

23.4±4.6

0.027

KOOS

 Symptom

96.2±4.7

73.9±16.2

<0.001

95.5±5.1

78.5±14.2

<0.001

 Pain

97.9±4.3

75.8±11.8

<0.001

97.8±4.0

75.4±14.2

<0.001

 Function

99.5±1.3

87.9±17.4

<0.001

99.3±1.8

88.1±12.4

<0.001

 QOL

94.5±9.1

55.9±17.4

<0.001

90.7±13.1

57.9±15.7

<0.001

KLG 0, n (%)

130 (78)

14 (82)

0.725

135 (73)

25 (66)

0.343

Effusion- area (mm 2 )

39.9±34.2

54.6±39.5

0.048

31.2±30.8

50.9±48.1

0.002

  1. The values represent the demographic data of all participants, including participants with EKOA (EKOA group) and those without EKOA (non-OA group). Data are presented as mean±standard deviation for the age, BMI, KOOS, and effusion area. The KLG data are based on the number of participants (percentage of the whole population). The Wilcoxon rank-sum test was used to compare the mean values of the age, BMI, KOOS, and effusion area. The chi-squared test was used to compare the proportions of KLG between participants with and without OA.
  2. BMI Body mass index, EKOA Early knee osteoarthritis, KOOS Knee injury and Osteoarthritis Outcome Score, KLG Kellgren–Lawrence grade, OA Osteoarthritis, QOL Quality of life